Hacker Newsnew | past | comments | ask | show | jobs | submitlogin
Intellia pauses phase 3 CRISPR trials after patient is hospitalized (fiercebiotech.com)
1 point by randycupertino 53 days ago | hide | past | favorite | 1 comment


CRISPR-based in vivo gene editing biotech Intellia voluntarily paused their Phase III ATTR PN and ATTR CM trials this morning after adverse liver effects in 1 patient.

Road towards the first commercially successful gene therapy continues to be rocky.




Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: